Cointime

Caxton Advantage Life Sciences Fund

investment firm

About

Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies in the life-science field.

Highlights

Investments
14
Lead Investments
6
Exits
6
Employee Profiles
1

Details

Operating Status
Active
Investor Type
Venture Capital

Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies in the life-science field.

Investments

Number of Investments
Number of Lead Investments
14
6
Caxton Advantage Life Sciences Fund has made 14 investments. Their most recent investment was on Nov 20, 2020, when VIVUS raised $33.60M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 20, 2020 VIVUS
Post-IPO Equity $33.60M Biopharma Yes
Aug 4, 2014 Mevion Medical Systems
Private Equity（PE） $200M Biotechnology —
Jun 25, 2013 Mevion Medical Systems
Private Equity（PE） $55M Biotechnology —
Dec 17, 2012 Regado Biosciences
Series E $51M Biotechnology —
Aug 24, 2010 Gemin X Pharmaceuticals
Series E $8M Biotechnology Yes
Show More

Employee Profiles

Number of Employee Profiles
1
Caxton Advantage Life Sciences Fund has 1 current employee profiles, including Executive Rachel Leheny
Rachel Leheny
Executive

Exits

Caxton Advantage Life Sciences Fund has had 6 exits. Caxton Advantage Life Sciences Fund most notable exits include Anthera Pharmaceuticals ,   Regado Biosciences

Date Company Name Exit Type Industry
Jun 28, 2018 Anthera Pharmaceuticals IPO Biotechnology Detail
Aug 22, 2013 Regado Biosciences IPO Biotechnology Detail
Mar 21, 2011 Gemin X Pharmaceuticals M&A Biotechnology Detail
Dec 23, 2009 Corthera M&A Biotechnology Detail
Oct 27, 2005 Sunesis Pharmaceuticals M&A Biotechnology Detail
Show More
Cointime
Content
Company